Native-like 3D colonoids reveal mechanisms of colonic drug disposition
In the authors' words
Intestinal organoid research in drug absorption, distribution, metabolism, excretion, and toxicity (ADME-T) has focused predominantly on small intestinal enteroids, leaving colonic drug handling comparatively unexplored. Here, we established and characterized adult colonic stem cell-based three-dimensional (3D) organoid (colonoid) models as physiologically relevant New Approach Methodologies (NAMs). Donor-matched mucosal tissue, isolated primary epithelial cells, and 3D colonoids were characterized using global and targeted proteomics, fixed and live-cell microscopy, functional ADME-T assays and targeted lipidomics. This complementary analysis identified isolated primary epithelial cells as a more representative native epithelial reference than excised mucosal tissue. Suspended differentiated apical- and basal-out colonoid configurations more closely matched this reference across the assessed characteristics. Together, these two configurations provided access to both apical and basolateral epithelial surfaces, enabling functional studies of key drug transporters (P-gp, BCRP) and metabolizing enzymes (CYP3A4, UGT1A, SULT1A) in a native-like setting. Measurement of intracellular bioavailability (Fic), reflecting drug availability to intracellular targets, revealed lipophilicity-dependent microvillar absorption mechanisms. Hydrophilic compounds exploited the enlarged membrane surface provided by microvilli, whereas highly permeable lipophilic compounds seemingly entered only at the microvillus tips. Compared with HEK293 cells, an established reference model for Fic measurements, colonoids combined native-like epithelial geometry with higher phospholipid content and generally stronger intracellular drug binding, highlighting the importance of both architecture and cellular composition for studying colonic drug disposition. These colonoid models provide a physiologically relevant platform for investigating colonic ADME-T and reveal how microvillar architecture shapes intracellular drug bioavailability.
Appeared: Wednesday, November 18. bioRxiv. Preprint, not yet peer-reviewed.